Literature DB >> 1352726

Behavioural analysis of unilateral monoamine depletion in the marmoset.

L E Annett1, D C Rogers, T D Hernandez, S B Dunnett.   

Abstract

Unilateral stereotaxic injections of 6-hydroxydopamine (6-OHDA) into the nigrostriatal bundle of marmosets (Callithrix jacchus) produced substantial losses of tyrosine hydroxylase immunoreactive neurons from the substantia nigra, and mean dopamine (DA) depletions of 98-99% in the caudate nucleus, putamen and nucleus accumbens, and of 91-97% in frontal cortex, on the side of the lesion. Noradrenaline (NA) and 5-hydroxytryptamine (5-HT) levels were also affected. Behavioural tests conducted pre-operatively and at regular intervals during the 6 mths following surgery revealed persistent deficits in the lesioned marmosets as a group compared with sham-lesioned controls, although individual marmosets sometimes recovered or showed no initial deficit on some tests. The main behavioural effects of the lesion were as follows: (i) an increase in the time spent with the head positioned ipsilaterally with respect to the rest of the body; (ii) ipsilateral spontaneous and amphetamine-induced rotation, although occasional intermittent periods of contralateral rotation and head biases were also recorded; (iii) contralateral apomorphine-induced rotation; (iv) reduced spontaneous activity; (v) ipsilateral hand preference on a conveyor belt task, although hand skill (measured as percentage errors when the speed of the belt was increased) was not affected; (vi) neglect of contralateral stimuli, both at the conveyor belt where lesioned monkeys often failed to respond on trials on which apple pieces arrived from the contralateral side, and on a test of sensorimotor neglect in which adhesive labels were placed around both feet. Comparisons of biochemical measures of the lesion with behavioural scores in individual monkeys suggest that DA depletions in excess of 95% are essential for long-term behavioural deficits.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352726     DOI: 10.1093/brain/115.3.825

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  13 in total

Review 1.  The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities.

Authors:  Claudio Da Cunha; Miriam Elizabeth Mendes Angelucci; Newton S Canteras; Susan Wonnacott; Reinaldo N Takahashi
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

2.  The marmoset monkey: a multi-purpose preclinical and translational model of human biology and disease.

Authors:  Bert A 't Hart; David H Abbott; Katsuki Nakamura; Eberhard Fuchs
Journal:  Drug Discov Today       Date:  2012-06-21       Impact factor: 7.851

3.  Brilliant Blue G, But Not Fenofibrate, Treatment Reverts Hemiparkinsonian Behavior and Restores Dopamine Levels in an Animal Model of Parkinson's Disease.

Authors:  Enéas G Ferrazoli; Héllio D N de Souza; Isis C Nascimento; Ágatha Oliveira-Giacomelli; Telma T Schwindt; Luiz R Britto; Henning Ulrich
Journal:  Cell Transplant       Date:  2017-04-13       Impact factor: 4.064

4.  Dopaminergic stimulation in unilateral neglect.

Authors:  G Geminiani; G Bottini; R Sterzi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-09       Impact factor: 10.154

5.  Spinal cord stimulation alleviates motor deficits in a primate model of Parkinson disease.

Authors:  Maxwell B Santana; Pär Halje; Hougelle Simplício; Ulrike Richter; Marco Aurelio M Freire; Per Petersson; Romulo Fuentes; Miguel A L Nicolelis
Journal:  Neuron       Date:  2014-10-30       Impact factor: 17.173

6.  Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease.

Authors:  Deniz Kirik; Lucy E Annett; Corinna Burger; Nicholas Muzyczka; Ronald J Mandel; Anders Björklund
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

Review 7.  Non-human primate models of PD to test novel therapies.

Authors:  Marc Morissette; Thérèse Di Paolo
Journal:  J Neural Transm (Vienna)       Date:  2017-04-08       Impact factor: 3.575

8.  Behavioral assessment of the ability of intracerebral embryonic neural tissue grafts to ameliorate the effects of brain damage in marmosets.

Authors:  R M Ridley; H F Baker; L E Annett; S B Dunnett; E M Torres; A Fine
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

9.  A comparison of the behavioural effects of embryonic nigral grafts in the caudate nucleus and in the putamen of marmosets with unilateral 6-OHDA lesions.

Authors:  L E Annett; E M Torres; R M Ridley; H F Baker; S B Dunnett
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

10.  NDRG2 as a marker protein for brain astrocytes.

Authors:  Gabriele Flügge; Carolina Araya-Callis; Enrique Garea-Rodriguez; Christine Stadelmann-Nessler; Eberhard Fuchs
Journal:  Cell Tissue Res       Date:  2014-05-10       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.